http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0#head http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0 http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0#assertion http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0 http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0#provenance http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0 http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0#publicationInfo http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0#assertion http://bio2rdf.org/drugbank:DB00214 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00214_DB01101 http://bio2rdf.org/drugbank:DB01101 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00214_DB01101 http://bio2rdf.org/drugbank_resource:DB00214_DB01101 http://purl.org/dc/terms/identifier drugbank_resource:DB00214_DB01101 http://bio2rdf.org/drugbank_resource:DB00214_DB01101 http://purl.org/dc/terms/title DDI between Torasemide and Capecitabine - Capecitabine, a strong CYP2C9 inhibitor, may increase the serum concentration of Torasemide, a CYP2C9 substrate, by decreasing Torasemide metabolism and clearance. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Torasemide if Capecitabine is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00214_DB01101 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00214_DB01101 http://www.w3.org/2000/01/rdf-schema#label DDI between Torasemide and Capecitabine - Capecitabine, a strong CYP2C9 inhibitor, may increase the serum concentration of Torasemide, a CYP2C9 substrate, by decreasing Torasemide metabolism and clearance. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Torasemide if Capecitabine is initiated, discontinued or dose changed. [drugbank_resource:DB00214_DB01101] http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0#provenance http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0#publicationInfo http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0#signature.MC0CFB12bIt0Ec6n http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0#signature.MC0CFB12bIt0Ec6n http://purl.org/nanopub/x/hasSignature MC0CFB12bIt0Ec6nAzRFvZAU5J2wo4JOAhUAgMqcncaA7dAwdPjft3JFwrbuuew= http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0#signature.MC0CFB12bIt0Ec6n http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0 http://purl.org/dc/terms/created 2018-03-30T11:12:36.924+02:00 http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0 http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0 http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0#signature.MC0CFB12bIt0Ec6n http://bio2rdf.org/drugbank_resource:DB00214_DB01101_nanopub.RAi_WGjVBQNljyaymklH3xibM97TKr8s-Dz_kQzSeeld0 http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234